Atlas Trials

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study

Clinical trial NCT07312422 · RECRUITING

Trial details

NCT number
NCT07312422
Sponsor
Zhejiang Provincial People's Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerPD-L1PD-1 InhibitorLDRTProterizumab
Start date
2025-09-30
Primary completion
2026-04-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.